1. Home
  2. ASTL vs CGEM Comparison

ASTL vs CGEM Comparison

Compare ASTL & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Algoma Steel Group Inc.

ASTL

Algoma Steel Group Inc.

HOLD

Current Price

$4.35

Market Cap

408.2M

Sector

Industrials

ML Signal

HOLD

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$9.67

Market Cap

671.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTL
CGEM
Founded
1902
2016
Country
Canada
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
408.2M
671.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ASTL
CGEM
Price
$4.35
$9.67
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$28.00
AVG Volume (30 Days)
1.4M
1.6M
Earning Date
10-29-2025
11-06-2025
Dividend Yield
2.31%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,589,572,318.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.02
$5.68
52 Week High
$9.99
$13.33

Technical Indicators

Market Signals
Indicator
ASTL
CGEM
Relative Strength Index (RSI) 55.78 45.54
Support Level $4.28 $9.48
Resistance Level $4.62 $13.10
Average True Range (ATR) 0.23 0.95
MACD 0.03 -0.34
Stochastic Oscillator 57.81 5.25

Price Performance

Historical Comparison
ASTL
CGEM

About ASTL Algoma Steel Group Inc.

Algoma Steel Group Inc is a fully integrated steel producer of hot and cold rolled steel products, including coiled sheet and plate, strategically located. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: